Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H14Cl2N2O |
| Molecular Weight | 297.18 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=C(C(CN2C=CN=C2)OCC=C)C(Cl)=C1
InChI
InChIKey=PZBPKYOVPCNPJY-UHFFFAOYSA-N
InChI=1S/C14H14Cl2N2O/c1-2-7-19-14(9-18-6-5-17-10-18)12-4-3-11(15)8-13(12)16/h2-6,8,10,14H,1,7,9H2
| Molecular Formula | C14H14Cl2N2O |
| Molecular Weight | 297.18 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Enilconazole is a synthetic broad-spectrum antimycotic with a high activity against most of the common dermatophytes and various other fungi and yeasts. It is a selective inhibitor of ergosterol biosynthesis, an essential component of the cell membrane of fungi and yeasts. This results in irreversible changes which are the origin of the fungicidal effect. Enilconazole is marketed under the brand name Imaverol among others. Imaverol concentrated solution is a synthetic antimycotic with a potent antifungal action against dermatophytes such as: Trichophyton verrucosum, Trichophyton mentagrophytes, Trichophyton equinum, and Microsporum canis in horses and dogs.
Originator
Sources: http://www.beckerdata.com/reg/ | https://archive.epa.gov/pesticides/reregistration/web/pdf/2325fact.pdf
Curator's Comment: # Janssen Pharmaceutica (Johnson & Johnson)
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL340 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19070657 |
|||
Target ID: CHEMBL2231 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19070657 |
|||
Target ID: O75469|||Q9UJ26 Gene ID: 8856.0 Gene Symbol: NR1I2 Target Organism: Homo sapiens (Human) |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | IMAVEROL Approved UseIMAVEROL concentrated solution is a synthetic antimycotic with a potent antifungal action against dermatophytes such as: Trichophyton verrucosum, Trichophyton mentagrophytes, Trichophyton equinum, and Microsporum canis in horses and dogs. Launch Date2012 |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 1.0 |
yes [IC50 0.1003 uM] | |||
Page: 3.0 |
yes [IC50 0.3869 uM] | |||
Page: 3.0 |
yes [IC50 0.6326 uM] | |||
Page: 4.0 |
yes [IC50 1.7888 uM] | |||
Page: 6.0 |
yes [IC50 4.4931 uM] | |||
Sources: https://pubmed.ncbi.nlm.nih.gov/21762035/ |
yes |
Tox targets
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 14.0 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effects of Common Pesticides on Prostaglandin D2 (PGD2) Inhibition in SC5 Mouse Sertoli Cells, Evidence of Binding at the COX-2 Active Site, and Implications for Endocrine Disruption. | 2016-04 |
|
| Cell-Based High-Throughput Screening for Aromatase Inhibitors in the Tox21 10K Library. | 2015-10 |
|
| A concentration addition model to assess activation of the pregnane X receptor (PXR) by pesticide mixtures found in the French diet. | 2014-09 |
|
| Inhibitory effects of azole-type fungicides on interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ. | 2012-03-15 |
|
| Environmental impact on vascular development predicted by high-throughput screening. | 2011-11 |
|
| Potential of an in vitro toolbox combined with exposure data as a first step for the risk assessment of dietary chemical contaminants. | 2011-09 |
|
| Widely used pesticides with previously unknown endocrine activity revealed as in vitro antiandrogens. | 2011-06 |
|
| Comparative study of human and mouse pregnane X receptor agonistic activity in 200 pesticides using in vitro reporter gene assays. | 2011-02-27 |
|
| Medical management of Trichophyton dermatophytosis using a novel treatment regimen in L'Hoest's monkeys (Cercopithecus lhoesti). | 2010-11-27 |
|
| Antimycotic effectiveness against dermatophytes: comparison of two in vitro tests. | 2010-06 |
|
| Eradication of feline dermatophytosis in a shelter: a field study. | 2010-06 |
|
| Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA's ToxCast program. | 2010-03-15 |
|
| Efficacy of intrasinusal administration of bifonazole cream alone or in combination with enilconazole irrigation in canine sino-nasal aspergillosis: 17 cases. | 2010-02 |
|
| Antifungal activity of tea tree oil from Melaleuca alternifolia against Trichophyton equinum: an in vivo assay. | 2009-11 |
|
| A zoospore inhibition technique to evaluate the activity of antifungal compounds against Batrachochytrium dendrobatidis and unsuccessful treatment of experimentally infected green tree frogs (Litoria caerulea) by fluconazole and benzalkonium chloride. | 2009-08 |
|
| Effects of the azole fungicide Imazalil on the development of the ascidian Ciona intestinalis (Chordata, Tunicata): morphological and molecular characterization of the induced phenotype. | 2009-02-19 |
|
| Successful treatment of a sinonasal cryptococcal granuloma in a horse. | 2009-02-15 |
|
| CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-comparison with other conazole pesticides. | 2009-02-10 |
|
| A lufenuron pre-treatment may enhance the effects of enilconazole or griseofulvin in feline dermatophytosis? | 2009-02 |
|
| A concentration addition model for the activation of the constitutive androstane receptor by xenobiotic mixtures. | 2009-01 |
|
| Enilconazole treatment of horses with superficial Aspergillus spp. rhinitis. | 2008-10-11 |
|
| Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism. | 2008-04 |
|
| Update on canine sinonasal aspergillosis. | 2007-09 |
|
| Correlation between digestion of the lipid phase of smedds and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from smedds. | 2007-05 |
|
| Long-term outcomes in dogs with sinonasal aspergillosis treated with intranasal infusions of enilconazole. | 2007-01-09 |
|
| Comparison of lanosterol-14 alpha-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles. | 2006-11-10 |
|
| Inhibition of rainbow trout (Oncorhynchus mykiss) P450 aromatase activities in brain and ovarian microsomes by various environmental substances. | 2006-11 |
|
| Surgical treatment of canine nasal aspergillosis by rhinotomy combined with enilconazole infusion and oral itraconazole. | 2006-06 |
|
| Combined clotrimazole irrigation and depot therapy for canine nasal aspergillosis. | 2006-06 |
|
| Identification of new human pregnane X receptor ligands among pesticides using a stable reporter cell system. | 2006-06 |
|
| Dysmorphogenic effects of some fungicides derived from the imidazole on rat embryos cultured in vitro. | 2006-01 |
|
| [Incidence, immunity and treatment of feline dermatophytosis]. | 2005-05 |
|
| Comparative assessment of the inhibition of recombinant human CYP19 (aromatase) by azoles used in agriculture and as drugs for humans. | 2004-08 |
|
| Development of an in vitro, isolated, infected spore testing model for disinfectant testing of Microsporum canis isolates. | 2004-06 |
|
| Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells. | 2004-04 |
|
| Treatment of dermatophytosis in dogs and cats: review of published studies. | 2004-04 |
|
| [Canine onychomycosis produced by Microsporum gypseum. A case report]. | 2003-12 |
|
| Allergic contact dermatitis from 1-[2-(2,4-dichlorophenyl)-2-(2-propenyloxy) ethyl]-1H-imidazole in a water-based metalworking fluid. | 2003-05 |
|
| Use of computed tomography to predict the outcome of a noninvasive intranasal infusion in dogs with nasal aspergillosis. | 2003-04 |
|
| Intranasal infusion of enilconazole for treatment of sinonasal aspergillosis in dogs. | 2002-11-15 |
|
| Evaluation of the efficacy of oral lufenuron combined with topical enilconazole for the management of dermatophytosis in catteries. | 2002-06-08 |
|
| Evaluation of topically applied enilconazole for the treatment of dermatophytosis in a Persian cattery. | 2002-02 |
|
| Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro. | 2000-06 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/vet/imaverol-can.html
The concentrated Imaverol (Enilconazole) is diluted in 50 parts of lukewarm water, which yields a 0.2% emulsion. Dispose of all unused diluted solutions.Dermatophytes will extend into the hair follicles. Possible crusts must therefore be removed with a hard brush, which has been soaked in the diluted IMAVEROL emulsion. It is highly recommended that the animal be sprayed entirely at the first treatment so as to reach the subclinical lesions as well.Horse: The lesions and surrounding skin are to be washed with the diluted emulsion 4 times at 3 to 4 day intervals.Dog: The animals are to be washed with the diluted emulsion 4 times at 3 to 4 day intervals.While doing this, one should rub thoroughly in the direction opposite to the hair growth to make sure that the skin is thoroughly wet. For the same reason, it is recommended to clip long-haired dogs prior to treatment.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22708367
A. niger strains were most susceptible to enilconazole. MIC ranged from 0.0625 to 0.5 ug/ml for enilconazole, with MIC90-0.5 ug/ml and MIC50-0.125 ug/ml.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:34:48 GMT 2025
by
admin
on
Mon Mar 31 17:34:48 GMT 2025
|
| Record UNII |
6K0NOF3XQ6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C514
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
||
|
WHO-VATC |
QD01AC90
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
||
|
EPA PESTICIDE CODE |
111901
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
73790-28-0
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
SUPERSEDED | |||
|
4921
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
252-615-0
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
6672
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
1442172
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | RxNorm | ||
|
81927
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
51004-46-7
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
SUPERSEDED | |||
|
C017435
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
m4907
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | Merck Index | ||
|
35554-44-0
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
CHEMBL356918
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
759313
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
3177
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
SUB183414
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
1135441-05-2
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
SUPERSEDED | |||
|
3177
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
DTXSID8024151
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
imazalil
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
C81505
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
6K0NOF3XQ6
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
100000169713
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
6K0NOF3XQ6
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
37175
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY | |||
|
ENILCONAZOLE
Created by
admin on Mon Mar 31 17:34:48 GMT 2025 , Edited by admin on Mon Mar 31 17:34:48 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |